|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wezensky SJ, Hanks TS, Wilkison MJ, Ammons
MC, Siemsen DW and Gauss KA: Modulation of PLAGL2 transactivation
by positive cofactor 2 (PC2), a component of the ARC/mediator
complex. Gene. 452:22–34. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kas K, Voz ML, Hensen K, Meyen E and Van
de Ven WJ: Transcriptional activation capacity of the novel PLAG
family of zinc finger proteins. J Biol Chem. 273:23026–23032. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Furukawa T, Adachi Y, Fujisawa J, Kambe T,
Yamaguchi-Iwai Y, Sasaki R, Kuwahara J, Ikehara S, Tokunaga R and
Taketani S: Involvement of PLAGL2 in activation of iron deficient-
and hypoxia-induced gene expression in mouse cell lines. Oncogene.
20:4718–4727. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soto A, Arce A, M KK and Vera JH: Effect
of the cation and the anion of an electrolyte on the solubility of
DL-aminobutyric acid in aqueous solutions: Measurement and
modelling. Biophys Chem. 73:77–83. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Landrette SF, Kuo YH, Hensen K, Barjesteh
van Waalwijk van Doorn-Khosrovani S, Perrat PN, Van de Ven WJ,
Delwel R and Castilla LH: Plag1 and Plagl2 are oncogenes that
induce acute myeloid leukemia in cooperation with Cbfb-MYH11.
Blood. 105:2900–2907. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang YS, Yang MC and Weissler JC:
Pleiomorphic adenoma gene-like 2 expression is associated with the
development of lung adenocarcinoma and emphysema. Lung Cancer.
74:12–24. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng H, Ying H, Wiedemeyer R, Yan H,
Quayle SN, Ivanova EV, Paik JH, Zhang H, Xiao Y, Perry SR, et al:
PLAGL2 regulates Wnt signaling to impede differentiation in neural
stem cells and gliomas. Cancer Cell. 17:497–509. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo J, Wang M, Wang Z and Liu X:
Overexpression of pleomorphic adenoma gene-like 2 is a novel poor
prognostic marker of prostate cancer. PLoS One. 11:e01586672016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu B, Lu C, Song YX, Gao P, Sun JX, Chen
XW, Wang MX, Dong YL, Xu HM and Wang ZN: The role of pleomorphic
adenoma gene-like 2 in gastrointestinal cancer development,
progression, and prognosis. Int J Clin Exp Pathol. 7:3089–3100.
2014.PubMed/NCBI
|
|
12
|
Su C, Li D, Li N, Du Y, Yang C, Bai Y, Lin
C, Li X and Zhang Y: Studying the mechanism of PLAGL2
overexpression and its carcinogenic characteristics based on
3′-untranslated region in colorectal cancer. Int J Oncol. 2018.
View Article : Google Scholar
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schwitalla S, Fingerle AA, Cammareri P,
Nebelsiek T, Göktuna SI, Ziegler PK, Canli O, Heijmans J, Huels DJ,
Moreaux G, et al: Intestinal tumorigenesis initiated by
dedifferentiation and acquisition of stem-cell-like properties.
Cell. 152:25–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Daughaday WH: The possible
autocrine/paracrine and endocrine roles of insulin-like growth
factors of human tumors. Endocrinology. 127:1–4. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hensen K, Van Valckenborgh IC, Kas K, Van
de Ven WJ and Voz ML: The tumorigenic diversity of the three PLAG
family members is associated with different DNA binding capacities.
Cancer Res. 62:1510–1517. 2002.PubMed/NCBI
|
|
18
|
Kas K, Voz ML, Roijer E, Aström AK, Meyen
E, Stenman G and Van de Ven WJ: Promoter swapping between the genes
for a novel zinc finger protein and beta-catenin in pleiomorphic
adenomas with t(3;8)(p21;q12) translocations. Nat Genet.
15:170–174. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Forbes SA, Beare D, Gunasekaran P, Leung
K, Bindal N, Boutselakis H, Ding M, Bamford S, Cole C, Ward S, et
al: COSMIC: Exploring the world's knowledge of somatic mutations in
human cancer. Nucleic Acids Res. 43:D805–D811. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Forbes SA, Beare D, Bindal N, Bamford S,
Ward S, Cole CG, Jia M, Kok C, Boutselakis H, De T, et al: COSMIC:
High-resolution cancer genetics using the catalogue of somatic
mutations in cancer. Curr Protoc Hum Genet. 91:1–10. 2016.
|
|
21
|
Forbes SA, Beare D, Boutselakis H, Bamford
S, Bindal N, Tate J, Cole CG, Ward S, Dawson E, Ponting L, et al:
COSMIC: Somatic cancer genetics at high-resolution. Nucleic Acids
Res. 45:D777–D783. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Batlle E, Henderson JT, Beghtel H, van den
Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering
M, Pawson T and Clevers H: Beta-catenin and TCF mediate cell
positioning in the intestinal epithelium by controlling the
expression of EphB/ephrinB. Cell. 111:251–263. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Anderson CB, Neufeld KL and White RL:
Subcellular distribution of Wnt pathway proteins in normal and
neoplastic colon. Proc Nati Acad Sci USA. 99:8683–8688. 2002.
View Article : Google Scholar
|
|
24
|
Munemitsu S, Albert I, Souza B, Rubinfeld
B and Polakis P: Regulation of intracellular beta-catenin levels by
the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc
Nati Acad Sci USA. 92:3046–3050. 1995. View Article : Google Scholar
|
|
25
|
Rosin-Arbesfeld R, Townsley F and Bienz M:
The APC tumour suppressor has a nuclear export function. Nature.
406:1009–1012. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kolligs FT, Bommer G and Goke B:
Wnt/beta-catenin/tcf signaling: A critical pathway in
gastrointestinal tumorigenesis. Digestion. 66:131–144. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van de Wetering M, Sancho E, Verweij C, de
Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D,
Haramis AP, et al: The beta-catenin/TCF-4 complex imposes a crypt
progenitor phenotype on colorectal cancer cells. Cell. 111:241–250.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sansom OJ, Meniel VS, Muncan V, Phesse TJ,
Wilkins JA, Reed KR, Vass JK, Athineos D, Clevers H and Clarke AR:
Myc deletion rescues Apc deficiency in the small intestine. Nature.
446:676–679. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shtutman M, Zhurinsky J, Simcha I,
Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A: The cyclin D1
gene is a target of the beta-catenin/LEF-1 pathway. Proc Nati Acad
S USA. 96:5522–5527. 1999. View Article : Google Scholar
|
|
30
|
Kawasaki H, Toyoda M, Shinohara H, Okuda
J, Watanabe I, Yamamoto T, Tanaka K, Tenjo T and Tanigawa N:
Expression of survivin correlates with apoptosis, proliferation,
and angiogenesis during human colorectal tumorigenesis. Cancer.
91:2026–2032. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wolfe SA, Nekludova L and Pabo CO: DNA
recognition by Cys2His2 zinc finger proteins. Annu Rev Biophys
Biomol Struct. 29:183–212. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Van Dyck F, Delvaux EL, Van de Ven WJ and
Chavez MV: Repression of the transactivating capacity of the
oncoprotein PLAG1 by SUMOylation. J Biol Chem. 279:36121–36131.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Voz ML, Agten NS, Van de Ven WJ and Kas K:
PLAG1, the main translocation target in pleomorphic adenoma of the
salivary glands, is a positive regulator of IGF-II. Cancer Res.
60:106–113. 2000.PubMed/NCBI
|
|
34
|
Strubberg AM, Veronese Paniagua DA, Zhao
T, Dublin L, Pritchard T, Bayguinov PO, Fitzpatrick JAJ and Madison
BB: The zinc finger transcription factor PLAGL2 enhances stem cell
fate and activates expression of ASCL2 in intestinal epithelial
cells. Stem Cell Reports. 11:410–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Van Dyck F, Declercq J, Braem CV and Van
de Ven WJ: PLAG1, the prototype of the PLAG gene family:
Versatility in tumour development (review). Int J Oncol.
30:765–774. 2007.PubMed/NCBI
|
|
36
|
Guo Y, Yang MC, Weissler JC and Yang YS:
Modulation of PLAGL2 transactivation activity by Ubc9 co-activation
not SUMOylation. Biochem Biophys Res Commun. 374:570–575. 2008.
View Article : Google Scholar : PubMed/NCBI
|
